Status:

COMPLETED

Spectroscopic Evaluation of Cervical Neoplasia

Lead Sponsor:

Guided Therapeutics

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Cervical Neoplasia

Eligibility:

FEMALE

16+ years

Brief Summary

The overall objective of this study is to evaluate whether fluorescence and reflectance spectroscopy can improve the ability to detect the presence of premalignant lesions on the cervix. The specific...

Detailed Description

If you agree to take part in this study, spectroscopic measurements on your cervix will be made for research purposes, prior to your routine colposcopy examination. MEASUREMENT PROCEDURE: The doctor...

Eligibility Criteria

Inclusion

  • Age 16 or above
  • Able to read or understand and give informed consent
  • Scheduled for colposcopy
  • Pap test within 120 days
  • Willing to undergo a Pap test and HPV test on day of study

Exclusion

  • Pregnancy
  • Menstruating on the day of colposcopy and CNDS test
  • Radiation therapy to her genitourinary system within 1 year
  • Prior hysterectomy
  • Congenital anatomical cervical variant (e.g., double cervix)
  • Friable cervix at the time of the study (i.e., a cervix that bleeds easily upon minimal contact or trauma)
  • Post-coital or other significant bleeding at the time of the exam
  • Excessive cervical mucous or discharge that cannot be removed and is significant enough, in the opinion of the investigator, to interfere with a Pap test or colposcopy, resulting from inflammatory, bacterial or other sources
  • History of any photosensitizing disease or other disease affected by Ultra-violet radiation, (e.g., pophyria, Lupus Erythematosus).
  • Undergoing phototherapy
  • Recent use of photosensitizing agents, such as fluoroquinolones or retinoids).
  • Patients who are pregnant are not eligible for this study.

Key Trial Info

Start Date :

January 1 2003

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

1599 Patients enrolled

Trial Details

Trial ID

NCT00766701

Start Date

January 1 2003

End Date

September 1 2008

Last Update

October 6 2008

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

University of Arkansas

Little Rock, Arkansas, United States, 72205

2

Orange Coast/Saddleback

Laguna Beach, California, United States, 92653

3

Saint Francis Hospital

Hartford, Connecticut, United States, 06112

4

University of Miami

Miami, Florida, United States, 33136

Spectroscopic Evaluation of Cervical Neoplasia | DecenTrialz